Clinical Trial Update: Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

View source ↗

Summary

An update on a second-line treatment trial for small cell lung cancer; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Groupe Francais De Pneumo-Cancerologie | Conditions: Small Cell Lung Cancer | Status: UNKNOWN